This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Lichtenstein Mathieu P , Carriba Paulina , Baltrons Maria Antonia , Wojciak-Stothard Beata , Peterson Jeffrey R , Garcia Agustina , Galea Elena
Secretase-independent and RhoGTPase/PAK/ERK-dependent regulation of cytoskeleton dynamics in astrocytes by NSAIDs and derivatives
Journal of Alzheimer's Disease. 2010 ;22(4) :1135-1155
PMID: Peer Reviewed Journal: 2011-00088-009
AbstractProfens like ibuprofen, R-flurbiprofen, or CHF5074 are being considered for the treatment of Alzheimer's disease because epidemiological data indicates that non-steroidal anti-inflammatory drugs are protective against neurodegeneration. Rho-GTPases are small G proteins, including RhoA, Cdc42, and Rac1, which control cytoskeleton dynamics. Because ibuprofen promotes axon growth via RhoA in neurons, we examined whether profens modulate astrocyte plasticity via Rho-GTPases. We report that ibuprofen (100-500 M), R-flurbiprofen (100-500 M), and CHF5074 (10-30 M) caused a concentration-dependent stellation of astrocytes in primary cultures, associated with the reorganization of GFAP and actin filaments. The stellation was independent of COX2, alpha -, beta - or gamma -secretase as judged by the lack of effect of inhibitors of these enzymes. RhoA, PAK, and Cdc42, but not Rac1, accounted for the profen-mediated stellation, as concluded from the joint analyses of activities and reversal experiments with adenoviral or pharmacological manipulations. Ibuprofen accelerated migration in a scratch-wound assay, while R-flurbiprofen had no effect and CHF5074 caused deceleration. Cell polarity regulation by Cdc42 and ERK1/2 may underlie the paradoxical effects of profens on migration. We conclude that profens regulate cytoskeleton dynamics in astrocytes via Rho-GTPases, PAK, and ERK1/2. Since migration is a hallmark of astrocyte response during inflammation we propose that, in addition to (or instead of) lowering amyloid-beta 42 via secretases, ibuprofen and its derivatives may prevent Alzheimer's disease by modulating astrocyte reactivity through Rho-GTPase/PAK/ERK-dependent signaling. (PsycINFO Database Record (c) 2010 APA, all rights reserved) (journal abstract).
NotesReferences Using Smart Source Parsing pp